Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study).
Warren H, Wagner T, Gorin MA, Rowe S, Holman BF, Pencharz D, El-Sheikh S, Barod R, Patki P, Mumtaz F, Bex A, Kasivisvanathan V, Moore CM, Campain N, Cartledge J, Scarsbrook A, Hassan F, O'Brien TS, Stewart GD, Mendichovszky I, Dizdarevic S, Alanbuki A, Wildgoose WH, Wah T, Vindrola-Padros C, Pizzo E, Dehbi HM, Lorgelly P, Gurusamy K, Emberton M, Tran MGB. Warren H, et al. Among authors: moore cm. BMJ Open. 2023 Jan 24;13(1):e067496. doi: 10.1136/bmjopen-2022-067496. BMJ Open. 2023. PMID: 36693694 Free PMC article.
Conceptual basis for focal therapy in prostate cancer.
Lecornet E, Ahmed HU, Moore CM, Emberton M. Lecornet E, et al. Among authors: moore cm. J Endourol. 2010 May;24(5):811-8. doi: 10.1089/end.2009.0654. J Endourol. 2010. PMID: 20443699
Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125.
Moore CM, Klotz L, Emberton M. Moore CM, et al. J Urol. 2011 Sep;186(3):1158-9; author reply 1159. doi: 10.1016/j.juro.2011.04.100. Epub 2011 Jul 23. J Urol. 2011. PMID: 21784490 No abstract available.
Re: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging: P. A. Pinto, P. H. Chung, A. R. Rastinehad, A. A. Baccala, Jr., J. Kruecker, C. J. Benjamin, S. Xu, P. Yan, S. Kadoury, C. Chua, J. K. Locklin, B. Turkbey, J. H. Shih, S. P. Gates, C. Buckner, G. Bratslavsky, W. M. Linehan, N. D. Glossop, P. L. Choyke and B. J. Wood J Urol 2011; 186: 1281-1285.
Robertson NL, Moore CM, Emberton M. Robertson NL, et al. Among authors: moore cm. J Urol. 2012 Apr;187(4):1511-2. doi: 10.1016/j.juro.2011.12.007. Epub 2012 Feb 17. J Urol. 2012. PMID: 22341821 No abstract available.
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
Kasivisvanathan V, Dufour R, Moore CM, Ahmed HU, Abd-Alazeez M, Charman SC, Freeman A, Allen C, Kirkham A, van der Meulen J, Emberton M. Kasivisvanathan V, et al. Among authors: moore cm. J Urol. 2013 Mar;189(3):860-6. doi: 10.1016/j.juro.2012.10.009. Epub 2012 Oct 11. J Urol. 2013. PMID: 23063807
716 results